Search by Drug Name or NDC
NDC 69097-0426-02 ENTECAVIR 0.5 mg/1 Details
ENTECAVIR 0.5 mg/1
ENTECAVIR is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is ENTECAVIR.
MedlinePlus Drug Summary
Entecavir is used to treat chronic (long-term) hepatitis B infection (swelling of the liver caused by a virus) in adults and children 2 years of age and older who have liver damage. Entecavir is in a class of medications called nucleoside analogs. It works by decreasing the amount of hepatitis B virus (HBV) in the body. Entecavir does not cure HBV and may not prevent complications of chronic hepatitis B such as cirrhosis of the liver or liver cancer. Entecavir does not prevent the spread of HBV to other people.
Related Packages: 69097-0426-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Entecavir
Product Information
| NDC | 69097-0426 |
|---|---|
| Product ID | 69097-426_f11e1153-612f-4924-86b1-6739d755e3c1 |
| Associated GPIs | 12352030000320 |
| GCN Sequence Number | 058934 |
| GCN Sequence Number Description | entecavir TABLET 0.5 MG ORAL |
| HIC3 | W5F |
| HIC3 Description | HEPATITIS B TREATMENT AGENTS |
| GCN | 24466 |
| HICL Sequence Number | 032832 |
| HICL Sequence Number Description | ENTECAVIR |
| Brand/Generic | Generic |
| Proprietary Name | ENTECAVIR |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ENTECAVIR |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | ENTECAVIR |
| Labeler Name | Cipla USA Inc. |
| Pharmaceutical Class | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206872 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69097-0426-02 (69097042602)
| NDC Package Code | 69097-426-02 |
|---|---|
| Billing NDC | 69097042602 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-426-02) |
| Marketing Start Date | 2016-12-06 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.36558 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ENTECAVIR 0.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis